PCR has revolutionized the diagnosis of genetic diseases by allowing for the rapid and precise amplification of specific DNA sequences associated with various conditions. Its high sensitivity enables the detection of even minute quantities of DNA, making it invaluable in identifying genetic mutations, deletions, or polymorphisms linked to diseases. For example, PCR can amplify genes known to be mutated in hereditary disorders like cystic fibrosis or Huntington's disease. The amplified DNA can then be sequenced or analysed using techniques like gel electrophoresis to identify specific genetic anomalies. This capability not only aids in early and accurate diagnosis but also enables carrier screening and prenatal testing, significantly impacting patient care and genetic counselling.

Host cells play a crucial role in recombinant DNA technology, serving as living factories for DNA replication and, often, protein expression. After the recombinant DNA is introduced into the host cell, typically using methods like transformation or transfection, the cell's machinery takes over. The host cell replicates the recombinant DNA along with its own DNA during cell division. This replication not only amplifies the DNA fragment of interest but can also lead to the production of the protein coded by the inserted gene, if expression conditions are met. Common host cells include E. coli bacteria due to their well-understood genetics, rapid growth, and ability to be easily manipulated. Yeast and mammalian cells are also used, especially for complex protein production where post-translational modifications are important.

Recombinant DNA technology has profoundly impacted vaccine development, enabling the production of safer and more effective vaccines. Traditional methods relied on weakened or inactivated forms of pathogens, posing risks of reversion to virulence or contamination. Recombinant DNA technology allows for the identification and production of specific pathogen antigens without the need to grow the pathogen itself. These antigens, when introduced into the body, stimulate an immune response, conferring protection against the disease. This approach has been used in the production of vaccines against hepatitis B, human papillomavirus (HPV), and influenza. Furthermore, recombinant DNA technology facilitates rapid vaccine development, as seen with the swift creation of vaccines in response to emerging infectious diseases, and allows for large-scale production, which is vital for global immunization programs.

PCR (Polymerase Chain Reaction) and gene cloning are both methods used to amplify DNA, but they differ significantly in their processes and applications. PCR is a quick, in vitro method for amplifying specific DNA segments, involving repeated cycles of heating and cooling to denature DNA, anneal primers, and extend the DNA strand. It's highly specific, can amplify DNA from small samples, and is commonly used in diagnostics, forensics, and research. In contrast, gene cloning involves inserting a DNA fragment into a vector (like a plasmid) and then introducing this vector into a host organism, usually bacteria. The host organism replicates, creating multiple copies of the DNA. Gene cloning is more time-consuming but is essential for producing recombinant proteins and for long-term study of genes in a functional state.

Restriction enzymes and DNA ligase work in tandem to facilitate the creation of recombinant DNA. Restriction enzymes, also known as molecular scissors, cut DNA at specific recognition sites, often leaving overhanging sections known as sticky ends. These enzymes are critical for cutting both the vector DNA, such as a plasmid, and the DNA fragment to be inserted, ensuring that they can be joined together. Once the desired DNA fragment is aligned with the sticky ends of the vector, DNA ligase comes into play. It acts like molecular glue, catalysing the formation of phosphodiester bonds between the adjacent phosphate and hydroxyl groups of the DNA backbone. This process effectively 'seals' the inserted DNA into the vector, creating a stable and continuous DNA molecule suitable for transformation into a host cell.